Non-invasive testing for liver pathology in alpha-1 antitrypsin deficiency

BACKGROUND: Many patients with alpha-1 antitrypsin deficiency (A1ATD) receive care in respiratory clinics without access to specialist hepatology expertise. Liver disease can develop asymptomatically, and non-invasive markers of fibrosis may help identify patients who require definitive assessment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Syed Hamza, Pickett, Elisha, Lomas, David A, Thorburn, Douglas, Gooptu, Bibek, Hurst, John R, Marshall, Aileen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Biomarkers of Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745521/
https://www.ncbi.nlm.nih.gov/pubmed/33323365
http://dx.doi.org/10.1136/bmjresp-2020-000820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745521/
https://www.ncbi.nlm.nih.gov/pubmed/33323365
http://dx.doi.org/10.1136/bmjresp-2020-000820

Ejemplares similares